Skip to main content

Table 3 Characteristics of included patients according to PCR result

From: Influenza epidemiology and influenza vaccine effectiveness during the 2014–2015 season: annual report from the Global Influenza Hospital Surveillance Network

 

Influenza-negative

Influenza-positive

A(H1N1)pdm09

A(H3N2)

B/Yamagata lineage

 

N = 7437

N = 2177

N = 115

N = 1231

N = 646

 

n

%

n

%

P vs. negative

n

%

P vs. negative

n

%

P vs. negative

n

%

P vs. negative

Age in years, median (range)

18.4 (0–106)

 

32.8 (0–100)

 

0.0001

5.6 (0–85)

 

0.0861

54.5 (0–100)

 

0.0001

26.2 (0–96)

 

0.0013

Age group

    

<0.0001

  

<0.0001

  

<0.0001

  

<0.0001

 0–1 y

1371

18.4

144

6.6

 

14

12.2

 

74

6.0

 

37

5.7

 

 2–4 y

1777

23.9

429

19.7

 

36

31.3

 

212

17.2

 

133

20.6

 

 5–17 y

547

7.4

280

12.9

 

14

12.2

 

121

9.8

 

118

18.3

 

 18–49 y

1038

14

423

19.4

 

28

24.3

 

183

14.9

 

168

26.0

 

 50–64 y

557

7.5

191

8.8

 

9

7.8

 

92

7.5

 

73

11.3

 

 65–74 y

608

8.2

211

9.7

 

5

4.3

 

153

12.4

 

45

7.0

 

 75–84 y

933

12.5

294

13.5

 

8

7.0

 

235

19.1

 

38

5.9

 

 ≥85

606

8.1

205

9.4

 

1

0.9

 

161

13.1

 

34

5.3

 

Sex

    

<0.0001

  

0.0390

  

0.0003

  

0.0040

 Male

4276

57.5

1141

52.4

 

55

47.8

 

651

52.9

 

333

51.5

 

 Female

3161

42.5

1036

47.6

 

60

52.2

 

580

47.1

 

313

48.5

 

Chronic conditions

    

0.0940

  

0.1600

  

<0.0001

  

0.004

 0

4572

61.5

1295

59.5

 

78

67.8

 

643

52.2

 

434

67.2

 

 ≥1

2865

38.5

882

40.5

 

37

32.2

 

588

47.8

 

212

32.8

 

Underlying chronic conditions

 Cardiovascular disease

1529

20.6

469

21.5

0.3210

18

15.7

0.1820

319

25.9

<0.0001

109

16.9

0.02200

 Chronic obstructive pulmonary disease

1153

15.5

306

14.1

0.0570

7

6.1

0.0001

222

18.0

0.0270

60

9.3

<0.0001

 Asthma

346

4.7

100

4.6

0.9080

5

4.3

0.8760

65

5.3

0.3440

24

3.7

0.2600

 Immunodeficiency/organ transplant

92

1.2

14

0.6

0.0130

0

0.0

0.0920

8

0.6

0.0550

6

0.9

0.4750

 Diabetes

814

10.9

234

10.7

0.7960

8

7.0

0.1480

180

14.6

<0.0001

34

5.3

<0.0001

 Renal impairment

463

6.2

143

6.6

0.5640

2

1.7

0.0200

108

8.8

0.0010

27

4.2

0.0280

 Neuromuscular disease

215

2.9

52

2.4

0.2020

8

7.0

0.0290

19

1.5

0.0040

22

3.4

0.4670

 Neoplasm

238

3.2

63

2.9

0.4660

4

3.5

0.8680

38

3.1

0.8330

17

2.6

0.4160

 Cirrhosis/liver disease

168

2.3

34

1.6

0.0390

0

0.0

0.0220

19

1.5

0.0950

11

1.7

0.3390

 Autoimmune disease

127

1.7

48

2.2

0.1360

1

0.9

0.4470

36

2.9

0.0060

8

1.2

0.3510

Pregnant (women 15–45 y)

138

33.7

160

64.8

0.0000

11

68.8

0.0050

64

55.7

<0.0001

68

70.1

<0.0001

Obese (all ages)

1300

17.5

358

16.4

0.2590

15

13.0

0.1970

223

18.1

0.5890

92

14.2

0.0320

Smoking habits (patients ≥18 y)

 Never smoked

1760

47.0

717

54.2

 

23

45.1

 

451

54.7

 

191

53.4

 

 Past smoker

1164

31.1

380

28.7

 

14

27.5

 

252

30.6

 

96

26.8

 

 Current smoker

818

21.9

227

17.1

 

14

27.5

 

121

14.7

 

71

19.8

 

Functional status impairment (Barthel score; patients ≥65 y)

 Total (0–15)

152

7.2

47

6.7

 

0

0.0

 

41

7.6

 

5

4.3

 

 Severe (20–35)

76

3.6

19

2.7

 

0

0.0

 

13

2.4

 

4

3.5

 

 Moderate (40–55)

140

6.7

46

6.6

 

0

0.0

 

32

5.9

 

11

9.6

 

 Mild (60–90)

518

24.7

148

21.1

 

1

7.1

 

111

20.5

 

32

27.8

 

 Minimal (95–100)

1214

57.8

441

62.9

 

13

92.9

 

345

63.7

 

63

54.8

 

Influenza vaccination ≥14 d since onset of symptoms

1566

21.1

447

20.5

0.5960

6

5.2

<0.0001

356

28.9

<0.0001

57

8.8

<0.0001

  1. Not subtyped A and B were 24 patients with mixed influenza infections were not included in the analysis by strain